Winslow Evans & Crocker’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-125
| Closed | -$6K | – | 1080 |
|
|
2020
Q2 | $6K | Sell |
125
-375
| -75% | -$18K | ﹤0.01% | 829 |
|
|
2020
Q1 | $22K | Hold |
500
| – | – | 0.01% | 553 |
|
|
2019
Q4 | $22K | Buy |
+500
| New | +$22K | 0.01% | 644 |
|
|
2018
Q2 | – | Sell |
-2,100
| Closed | -$47.2K | – | 1124 |
|
|
2018
Q1 | $47.2K | Sell |
2,100
-650
| -24% | -$14.6K | 0.02% | 490 |
|
|
2017
Q4 | $82.8K | Sell |
2,750
-1,050
| -28% | -$31.6K | 0.03% | 400 |
|
|
2017
Q3 | $143K | Sell |
3,800
-1,300
| -25% | -$49K | 0.05% | 300 |
|
|
2017
Q2 | $142K | Hold |
5,100
| – | – | 0.04% | 369 |
|
|
2017
Q1 | $175K | Buy |
5,100
+1,600
| +46% | +$55K | 0.06% | 314 |
|
|
2016
Q4 | $101K | Buy |
3,500
+1,100
| +46% | +$31.7K | 0.03% | 404 |
|
|
2016
Q3 | $76.3K | Sell |
2,400
-2,000
| -45% | -$63.6K | 0.02% | 455 |
|
|
2016
Q2 | $143K | Buy |
4,400
+2,400
| +120% | +$77.9K | 0.04% | 316 |
|
|
2016
Q1 | $55.9K | Buy |
2,000
+1,000
| +100% | +$28K | 0.02% | 473 |
|
|
2015
Q4 | $35.7K | Hold |
1,000
| – | – | 0.01% | 601 |
|
|
2015
Q3 | $33.1K | Buy |
+1,000
| New | +$33.1K | 0.01% | 588 |
|